New Anticoagulants-Reference-Cited by-同舟云学术

New Anticoagulants

Published:2010-04-06 Issue:13 Volume:121 Page:1523-1532
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Eikelboom John W.¹,Weitz Jeffrey I.¹

Affiliation:

1. From the Department of Medicine, McMaster University (J.W.E., J.I.W.), and Department of Biochemistry and Medical Sciences and Henderson Research Centre (J.I.W.), Hamilton, Ontario, Canada.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference49 articles.

1. Parenteral Anticoagulants

2. Pharmacology and Management of the Vitamin K Antagonists

3. New Antithrombotic Drugs

4. The direct thrombin inhibitor ximelagatran/melagatran: a systematic review on clinical applications and an evidence based assessment of risk benefit profile

5. Dabigatran versus Warfarin in Patients with Atrial Fibrillation

Cited by 251 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is there a potential role of inhibition of thrombin-activatable fibrinolysis inhibitor in regulation of local fibrinolytic activities on fibrin thrombi in patients with pulmonary embolism?;Journal of Thrombosis and Haemostasis;2023-10

2. Anticoagulant use in older persons at risk for falls: therapeutic dilemmas—a clinical review;European Geriatric Medicine;2023-07-01

3. Anticoagulant Macromolecules;Macromolecules;2023-06-13

4. Clinical Use of Direct Oral Anticoagulants and Reversal: Consideration for Vascular Surgeons;Journal of Vascular Diseases;2023-06-01

5. Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis;Cochrane Database of Systematic Reviews;2023-04-14